Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
NCT00811889 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 227
Last updated 2025-05-29
Summary
This study assesses the effects of bardoxolone methyl (RTA 402) in patients with type 2 diabetes and chronic kidney disease.
Conditions
- Chronic Kidney Disease
- Type 2 Diabetes
- Diabetic Nephropathy
Interventions
- OTHER
-
Placebo
Placebo
- DRUG
-
Bardoxolone Methyl (RTA 402)
Oral, Once Daily
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-05-31
- Completion
- 2010-12-31
Countries
- United States
Study Locations
More Related Trials
-
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01351675 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment
NCT01555008 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01551446 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated
NCT03550378 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
NCT01847092 ·Status: COMPLETED ·Phase: PHASE2
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
NCT01487109 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Participants With Diabetic Kidney Disease
NCT01113801 ·Status: TERMINATED ·Phase: PHASE2
-
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
NCT02251431 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01574365 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
NCT04750577 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
NCT01986855 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2b Diabetic Kidney Disease Study
NCT04170543 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
NCT02540993 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
NCT04515849 ·Status: COMPLETED ·Phase: PHASE2
-
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
NCT04990427 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02312050 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
NCT01683409 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus
NCT01030679 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
NCT07271186 ·Status: RECRUITING ·Phase: PHASE2
-
First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes
NCT04880291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)
NCT01893242 ·Status: WITHDRAWN ·Phase: PHASE3
-
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT07116928 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
NCT06222476 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
NCT00663260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3